W8NB Stock Overview
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
AquaBounty Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.34 |
| 52 Week High | US$16.60 |
| 52 Week Low | US$4.15 |
| Beta | 1.31 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -94.10% |
| 5 Year Change | n/a |
| Change since IPO | -89.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| W8NB | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | 4.5% | -1.3% |
| 1Y | n/a | -13.9% | 4.1% |
Rentabilidad frente al sector: Datos insuficientes para determinar los resultados de W8NB en comparación con el sector German Biotechs .
Rentabilidad vs. Mercado: Datos insuficientes para determinar el rendimiento de W8NB frente al mercado German.
Price Volatility
| W8NB volatility | |
|---|---|
| W8NB Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 9.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: W8NB no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de W8NB en el último año.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 100 | Sylvia Wulf | https://www.aquabounty.com |
AquaBounty Technologies, Inc. Fundamentals Summary
| W8NB fundamental statistics | |
|---|---|
| Market cap | €13.87m |
| Earnings (TTM) | -€23.23m |
| Revenue (TTM) | €2.17m |
6.4x
P/S Ratio-0.6x
P/E RatioIs W8NB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| W8NB income statement (TTM) | |
|---|---|
| Revenue | US$2.29m |
| Cost of Revenue | US$14.46m |
| Gross Profit | -US$12.16m |
| Other Expenses | US$12.34m |
| Earnings | -US$24.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.87 |
| Gross Margin | -531.06% |
| Net Profit Margin | -1,069.75% |
| Debt/Equity Ratio | 4.9% |
How did W8NB perform over the long term?
See historical performance and comparison